Kiniksa Pharmaceuticals, Ltd. [KNSA] has reported fiscal Q1 profit of $12.30 million.
On a per-share basis, the D0 based company said its diluted earnings are $0.18.
The Pharmaceutical Preparations firm posted revenue of $48.30 million in this period.
Also Read: